Market closed
Grifols Class A/€GRF
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Grifols Class A
Grifols SA, operating under the ticker GRF, is a biopharmaceutical company specialized in the production of plasma-derived medicines. Founded in 1940 and headquartered in Barcelona, Spain, Grifols is engaged in the diagnosis, prevention, and treatment of a variety of diseases, with a strong focus on immunology, hematology, and intensive care sectors. The company operates globally, leveraging advanced technologies and rigorous quality processes to provide essential medical products.
Ticker
€GRF
Sector
Trading on
BME
Industry
Biotechnology
Headquarters
Employees
23,000
Website
Grifols Class A Metrics
BasicAdvanced
€5.7B
Market cap
39.23
P/E ratio
€0.24
EPS
0.70
Beta
-
Dividend rate
Price and volume
Market cap
€5.7B
Beta
0.7
52-week high
€15.92
52-week low
€6.36
Average daily volume
2.4M
Financial strength
Current ratio
2.26
Quick ratio
0.77
Long term debt to equity
110.521
Total debt to equity
123.24
Interest coverage (TTM)
1.61%
Management effectiveness
Return on assets (TTM)
2.87%
Return on equity (TTM)
2.71%
Valuation
Price to earnings (TTM)
39.231
Price to revenue (TTM)
0.904
Price to book
1.07
Price to tangible book (TTM)
-1.08
Price to free cash flow (TTM)
30.292
Growth
Revenue change (TTM)
7.21%
3-year revenue growth (CAGR)
11.57%
3-year earnings per share growth (CAGR)
-23.28%
What the Analysts think about Grifols Class A
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Grifols Class A stock.
Grifols Class A Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Grifols Class A Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Grifols Class A stock?
Grifols Class A (GRF) has a market cap of €5.7B as of December 22, 2024.
What is the P/E ratio for Grifols Class A stock?
The price to earnings (P/E) ratio for Grifols Class A (GRF) stock is 39.23 as of December 22, 2024.
Does Grifols Class A stock pay dividends?
No, Grifols Class A (GRF) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Grifols Class A dividend payment date?
Grifols Class A (GRF) stock does not pay dividends to its shareholders.
What is the beta indicator for Grifols Class A?
Grifols Class A (GRF) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.